FDA Approves New Pancreatic Cancer Drug

THURSDAY, Oct. 22, 2015 — The U.S. Food and Drug Administration has approved a new drug called Onivyde as part of a treatment regimen for advanced pancreatic cancer.
Onivyde (irinotecan liposome injection) was approved to be used in combination…
Source: Topamax